NGBiLab S3.E1: Canurta Therapeutics
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
NGBiLab S3.E1: Canurta Therapeutics
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of NGBi Lab, host Jim Wilson welcomes Akeem Gardner, CEO and Founder of Canurta Therapeutics. Discover how Akeem transitioned from law school and farming into the biotech space to build a company developing botanical drug candidates for neurodegenerative diseases, with a lead program targeting ALS.
From his unconventional entrepreneurial journey and the shift from ingredient supplier to full biotechnology company, to the stark financial realities of funding clinical trials, this conversation dives deep into the conviction and risk required to innovate in the life sciences sector.
Tune in to learn about his vision for Canurta Therapeutics and what it really takes to run a startup.
Pas encore de commentaire